Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN: Safety Overview

Metric FOSCARBIDOPA\FOSLEVODOPA FOSFOMYCIN
Total FAERS Reports 3,161 828
Deaths Reported 431 128
Death Rate 13.6% 15.5%
Hospitalizations 1,747 407
Average Patient Age 70.4 yrs 55.3 yrs
% Female Patients 42.2% 57.3%
FDA Approval Date N/A Oct 22, 2025
Manufacturer N/A Meitheal Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription